Researchers sought to determine whether screening patients with MM after ASCT with FDG-PET would be able to identify patients with residual disease.
Researchers evaluated data from 270 patients with MM undergoing spine surgery to determine complication and reoperation rates.
Use of vitamin C and D supplementation evaluated for its efficacy for patients with AML undergoing intensive induction chemotherapy.
Aphexda is expected to be available in September 2023.
New data suggest that, from 1990 to 2019, the global incidence of early-onset cancer increased by nearly 80%, and the rate of early-onset cancer deaths increased by nearly 30%.